LINFOMAS Y TRASPLANTES
University of Alabama at Birmingham
Birmingham, Estados UnidosPublications in collaboration with researchers from University of Alabama at Birmingham (1)
2018
-
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204